Literature DB >> 33946859

Prenatal Ultrasound Suspicion of Cystic Fibrosis in a Multiethnic Population: Is Extensive CFTR Genotyping Needed?

Chadia Mekki1, Abdel Aissat1,2, Véronique Mirlesse3,4, Sophie Mayer Lacrosniere5, Elsa Eche3, Annick Le Floch1, Sandra Whalen6, Cecile Prud'Homme6, Christelle Remus7, Benoit Funalot1,2,7, Vanina Castaigne8, Pascale Fanen1,2, Alix de Becdelièvre1,2.   

Abstract

In families without a Cystic Fibrosis (CF) history, fetal ultrasound bowel abnormalities can unexpectedly reveal the disease. Isolated or in association, the signs can be fetal bowel hyperechogenicity, intestinal loop dilatation and non-visualization of fetal gallbladder. In these cases, search for CF transmembrane conductance regulator (CFTR) gene mutations is part of the recommended diagnostic practices, with a search for frequent mutations according to ethnicity, and, in case of the triad of signs, with an exhaustive study of the gene. However, the molecular diagnosis remains a challenge in populations without well-known frequent pathogenic variants. We present a multiethnic cohort of 108 pregnancies with fetal bowel abnormalities in which the parents benefited from an exhaustive study of the CFTR gene. We describe the new homozygous p.Cys1410* mutation in a fetus of African origin. We did not observe the most frequent p.Phe508del mutation in our cohort but evidenced variants undetected by our frequent mutations kit. Thanks to the progress of sequencing techniques and despite the difficulties of interpretation occasionally encountered, we discuss the need to carry out a comprehensive CFTR study in all patients in case of fetal bowel abnormalities.

Entities:  

Keywords:  Africa; CFTR; Cystic Fibrosis (CF); echogenic bowel; mutation; non-Caucasian; non-visualization of fetal gallbladder (NVFGB); prenatal

Year:  2021        PMID: 33946859     DOI: 10.3390/genes12050670

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  47 in total

Review 1.  Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells.

Authors:  Fabrice Lejeune; Lynne E Maquat
Journal:  Curr Opin Cell Biol       Date:  2005-06       Impact factor: 8.382

2.  Antenatal prognostic factor of fetal echogenic bowel.

Authors:  Candice Ronin; Pierre Mace; Fabien Stenard; Anderson Loundou; Marianne Capelle; Isabelle Mortier; Marie Christine Pellissier; Sabine Sigaudy; Annie Levy; Claude D'ercole; Pascale Hoffmann; Thierry Merrot; Jonathan Lopater; Pascal De Lagausie; Nicole Philip; Florence Bretelle
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-03-03       Impact factor: 2.435

3.  Functional characterization and phenotypic spectrum of three recurrent disease-causing deep intronic variants of the CFTR gene.

Authors:  A Bergougnoux; K Délétang; A Pommier; J Varilh; F Houriez; J P Altieri; M Koenig; C Férec; M Claustres; G Lalau; T Bienvenu; M P Audrézet; A Pagin; E Girodon; C Raynal; M Taulan-Cadars
Journal:  J Cyst Fibros       Date:  2018-10-30       Impact factor: 5.482

4.  Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations.

Authors:  B Strandvik; E Björck; M Fallström; E Gronowitz; J Thountzouris; A Lindblad; D Markiewicz; J Wahlström; L C Tsui; J Zielenski
Journal:  Genet Test       Date:  2001

5.  Reference curves for the normal fetal small bowel and colon diameters; their usefulness in fetuses with suspected dilated bowel.

Authors:  Chiara C Lap; Charlotte S Voskuilen; Lourens R Pistorius; Eduard J H Mulder; Gerard H A Visser; Gwendolyn T R Manten
Journal:  J Matern Fetal Neonatal Med       Date:  2019-01-06

6.  Bowel abnormalities in the fetus--correlation of prenatal ultrasonographic findings with outcome.

Authors:  J E Corteville; D L Gray; J C Langer
Journal:  Am J Obstet Gynecol       Date:  1996-09       Impact factor: 8.661

7.  Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.

Authors:  F Muller; B Simon-Bouy; E Girodon; N Monnier; M C Malinge; J L Serre
Journal:  Am J Med Genet       Date:  2002-06-15

Review 8.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  CADD: predicting the deleteriousness of variants throughout the human genome.

Authors:  Philipp Rentzsch; Daniela Witten; Gregory M Cooper; Jay Shendure; Martin Kircher
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  1 in total

1.  A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening.

Authors:  Zoran Laurentiu Popa; Madalin-Marius Margan; Izabella Petre; Elena Bernad; Lavinia Stelea; Veronica Daniela Chiriac; Marius Craina; Ioana Mihaela Ciuca; Anca Mihaela Bina
Journal:  Int J Environ Res Public Health       Date:  2022-07-17       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.